Morepen Laboratories secures a ₹825 crore CDMO mandate from a global pharmaceutical company, boosting shares by 14.58 percent. Supplies start in four to five months, marking a major milestone.
Morepen Laboratories secures a ₹825 crore CDMO mandate from a global pharmaceutical company, boosting shares by 14.58 percent. Supplies start in four to five months, marking a major milestone.